Search Results - MUNSTER, Pam

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms

    A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms by Wolin, Edward, Mita, Alain, Mahipal, Amit, Meyer, Tim, Bendell, Johanna, Nemunaitis, John, Munster, Pam N, Paz-Ares, Luis, Filvaroff, Ellen H, Li, Shaoyi, Hege, Kristen, de Haan, Hans, Mita, Monica

    Published in PloS one
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Phase II Trial of Tipifarnib plus Neoadjuvant Doxorubicin-Cyclophosphamide in Patients with Clinical Stage IIB-IIIC Breast Cancer

    Phase II Trial of Tipifarnib plus Neoadjuvant Doxorubicin-Cyclophosphamide in Patients with Clinical Stage IIB-IIIC Breast Cancer by SPARANO, Joseph A, MOULDER, Stacy, MALAFA, Mokenge, LEE, David, HOSCHANDER, Shira, HOPKINS, Una, HERSHMAN, Dawn, WRIGHT, John J, KLEER, Celina, MERAJVER, Sofia, SEBTI, Said M, KAZI, Aslamuzzaman, COPPOLA, Domenico, NEGASSA, Abdissa, VAHDAT, Linda, TIANHONG LI, PELLEGRINO, Christine, FINEBERG, Susan, MUNSTER, Pam

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor

    A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor by Wolin, Edward, Mita, Alain, Mahipal, Amit, Meyer, Tim, Bendell, Johanna, Nemunaitis, John, Munster, Pam N, Paz-Ares, Luis, Filvaroff, Ellen H, Li, Shaoyi, Hege, Kristen, de Haan, Hans, Mita, Monica

    Published in PloS one
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Phase II trial of the farnesyl transferase inhibitor tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer

    Phase II trial of the farnesyl transferase inhibitor tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer by Sparano, Joseph A., Moulder, Stacy, Kazi, Aslamuzzaman, Coppola, Domenico, Negassa, Abdissa, Vahdat, Linda, Li, Tianhong, Pellegrino, Christine, Fineberg, Susan, Munster, Pam, Malafa, Mokenge, Lee, David, Hoschander, Shira, Hopkins, Una, Hershman, Dawn, Wright, John J., Kleer, Celina, Merajver, Sofia, Sebti, Said M.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: